TCM

₹58.5 2.7 | 4.9%

WEBSITE BSE:524156 NSE : T C M LTD. 18 May, 12:50

Market Cap ₹44 Cr.

Stock P/E -16.8

P/B 1.5

Current Price ₹58.5

Book Value ₹ 38.9

Face Value 10

52W High ₹67

Dividend Yield 0%

52W Low ₹ 32.5

Edit Ratio

TCM Research see more...

Overview Inc. Year: 1943Industry: Chemicals

TCM Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

TCM Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	1	0	1	1	1	1	5	7	5	11
Other Income	0	0	1	0	0	0	0	0	0	0
Total Income	1	0	2	1	1	1	5	7	5	11
Total Expenditure	1	1	3	2	1	2	6	8	7	11
Operating Profit	-0	-1	-1	-1	-0	-1	-1	-1	-2	1
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	-3	0	0	0	0	0	0	0
Profit Before Tax	-0	-1	-4	-1	-1	-1	-1	-1	-2	1
Provision for Tax	0	0	-0	0	0	0	-0	0	0	0
Profit After Tax	-0	-1	-4	-1	-1	-1	-1	-1	-2	1
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	0	-1	-4	-1	-1	-1	-1	-1	-2	1
Adjusted Earnings Per Share	0.2	-1.6	-7.3	-1.5	-0.8	-1.7	-1.4	-0.9	-2.2	1

TCM Profit & Loss

#(Fig in Cr.)	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	0	1	4	4	7	28
Other Income	0	1	1	1	0	0
Total Income	0	2	5	4	7	28
Total Expenditure	1	2	5	8	11	32
Operating Profit	-1	0	0	-3	-4	-3
Interest	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	-3	0	0
Profit Before Tax	-1	0	0	-6	-4	-3
Provision for Tax	0	0	0	-0	-0	0
Profit After Tax	-1	0	0	-6	-4	-3
Adjustments	0	0	0	1	0	0
Profit After Adjustments	-1	0	0	-5	-4	-3
Adjusted Earnings Per Share	-1.7	0.6	0.2	-9.4	-5.4	-3.5

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	75%	91%	0%	0%
Operating Profit CAGR	0%	0%	0%	0%
PAT CAGR	0%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	66%	15%	14%	2%
ROE Average	-15%	-5%	-3%	-3%
ROCE Average	-13%	-45%	-27%	-27%

TCM Balance Sheet

#(Fig in Cr.)	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	32	32	33	25	31
Minority's Interest	0	0	0	-1	-1
Borrowings	0	0	0	0	0
Other Non-Current Liabilities	20	20	20	20	20
Total Current Liabilities	17	13	15	17	19
Total Liabilities	69	65	68	61	69
Fixed Assets	58	58	59	55	36
Other Non-Current Assets	2	2	3	2	4
Total Current Assets	9	5	6	5	9
Total Assets	69	65	68	61	69

TCM Cash Flow

#(Fig in Cr.)	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	4	0	0	0
Cash Flow from Operating Activities	-2	-1	0	-4	-11
Cash Flow from Investing Activities	0	0	-1	4	6
Cash Flow from Financing Activities	5	-3	0	0	5
Net Cash Inflow / Outflow	4	-4	0	0	-0
Closing Cash & Cash Equivalent	4	0	0	0	0

TCM Ratios

#	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-1.74	0.56	0.22	-9.43	-5.35
CEPS(Rs)	-1.73	0.57	0.27	-10.47	-5.21
DPS(Rs)	0	0	0	0	0
Book NAV/Share(Rs)	-53.17	-51.87	-51.65	46.49	41.11
Core EBITDA Margin(%)	-218.08	-90.44	-19.16	-112.59	-49.94
EBIT Margin(%)	-208.51	33.73	9.16	-165.08	-54.71
Pre Tax Margin(%)	-239.33	33.1	8.87	-165.46	-58.46
PAT Margin (%)	-239.33	33.1	2.79	-165.4	-58.14
Cash Profit Margin (%)	-238.35	33.71	3.51	-160.53	-53.07
ROA(%)	-1.37	0.45	0.18	-9.1	-6.56
ROE(%)	0	0	0	0	-15.24
ROCE(%)	0	0	0	-123.47	-12.55
Receivable days	1393.38	653.71	184.76	226.81	163.71
Inventory Days	1565.51	636.24	168.31	193.84	127.99
Payable days	2568.13	1784.19	703.75	306.95	57.75
PER(x)	0	0	115	0	0
Price/Book(x)	-0.56	0	-0.48	0.65	0.81
Dividend Yield(%)	0	0	0	0	0
EV/Net Sales(x)	45.17	9.81	4.56	6.4	3.54
EV/Core EBITDA(x)	-21.77	28.58	46.09	-7.3	-7.12
Net Sales Growth(%)	0	132.34	361.81	-16.36	106.71
EBIT Growth(%)	0	137.58	25.42	-1607.27	31.5
PAT Growth(%)	0	132.13	-61.13	-5065.54	27.34
EPS Growth(%)	0	132.08	-61.13	-4444.94	43.2
Debt/Equity(x)	-0.19	-0.2	-0.21	0.26	0.05
Current Ratio(x)	0.51	0.38	0.39	0.26	0.5
Quick Ratio(x)	0.41	0.27	0.24	0.18	0.3
Interest Cover(x)	-6.76	53.52	31.4	-434.65	-14.59
Total Debt/Mcap(x)	0.33	0	0.43	0.4	0.06

TCM Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	36.8	36.8	47.25	47.25	47.25	47.25	47.25	49.51	49.51	49.51
FII	0	0	0	0	0	0	0	0	0	0
DII	24.99	24.84	11.29	10.3	10.02	8.7	7.71	7.71	7.71	7.71
Public	38.21	38.35	41.46	42.45	42.73	44.06	45.05	42.78	42.78	42.78
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.13	0.13	0.35	0.35	0.35	0.35	0.35	0.37	0.37	0.37
FII	0	0	0	0	0	0	0	0	0	0
DII	0.08	0.08	0.08	0.08	0.07	0.07	0.06	0.06	0.06	0.06
Public	0.13	0.13	0.31	0.32	0.32	0.33	0.34	0.32	0.32	0.32
Others	0	0	0	0	0	0	0	0	0	0
Total	0.34	0.34	0.75	0.75	0.75	0.75	0.75	0.75	0.75	0.75

Pros

Debtor days have improved from 306.95 to 57.75days.
Company is almost debt free.

Cons

Promoter holding is low: 49.51%.
Company has a low return on equity of -5% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.